Elite Pharmaceuticals, Inc. Proceeds from (Repayments of) Debt
Elite Pharmaceuticals, Inc. (ELTP) reported Proceeds from (Repayments of) Debt of $857.38 thousand for the 12-month period ending 2022-03-31, per its 10-K filed 2022-06-29.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromRepaymentsOfDebt · last filed 2022-06-29
- Elite Pharmaceuticals, Inc. proceeds from (repayments of) debt for the quarter ending 2022-03-31 was $0.00.
- Elite Pharmaceuticals, Inc. proceeds from (repayments of) debt for the quarter ending 2021-12-31 was $0.00.
- Elite Pharmaceuticals, Inc. proceeds from (repayments of) debt for the quarter ending 2021-09-30 was $2.03K.
- Elite Pharmaceuticals, Inc. proceeds from (repayments of) debt for the quarter ending 2021-06-30 was $855.35K, a 9.62% decline year-over-year.
- Elite Pharmaceuticals, Inc. proceeds from (repayments of) debt for fiscal 2022 was $857.38K.
| Period end | Proceeds from (Repayments of) Debt 1 month | Proceeds from (Repayments of) Debt 3 month | Proceeds from (Repayments of) Debt 6 month | Proceeds from (Repayments of) Debt 9 month | Proceeds from (Repayments of) Debt 12 month |
|---|---|---|---|---|---|
| 2022-03-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-06-29 | $0.00 derived: sum of 2 quarters · filed 2022-06-29 | $2.03K derived: sum of 3 quarters · filed 2022-06-29 | $857.38K 10-K · filed 2022-06-29 | |
| 2021-12-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-02-14 | $2.03K derived: sum of 2 quarters · filed 2022-02-14 | $857.38K 10-Q · filed 2022-02-14 | ||
| 2021-09-30 | $2.03K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-11-15 | $857.38K 10-Q · filed 2021-11-15 | |||
| 2021-06-30 | $855.35K 10-Q · filed 2021-08-16 | ||||
| 2020-09-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-11-15 | $946.41K 10-Q · filed 2021-11-15 | |||
| 2020-06-30 | $946.41K 10-Q · filed 2021-08-16 | ||||
| 2020-04-30 | $946.41K 10-K · filed 2021-06-14 |